Inventiva IVA
NASDAQ IVA
$3.87 +0.03 (+0.65%)
As of: Nov 10, 2026 · 1:39 PM EST

Inventiva (IVA) Share-based Compensation (2020 - 2021)

Updated

Inventiva's Share-based Compensation came in at $31.16 million for FY2025, up 714.5% from $3.83 million in FY2024.

Analysis

Inventiva (IVA) Share-based Compensation (2020 - 2021) Analysis & Trends

Going back to FY2018, Inventiva's Share-based Compensation data covers 8 years.

  • Share-based Compensation carries a five-year compound annual growth rate of 96.2% (FY2020 to FY2025).
  • The FY2025 figure represents the highest annual Share-based Compensation in data going back to FY2018.
  • Per Business Quant, earlier years put Share-based Compensation at $3.83 million in FY2024 (-10.4%), $4.27 million in FY2023 (+88.7%), $2.26 million in FY2022 (-8.5%) and $2.47 million in FY2021 (+130.8%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 357.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 160.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 234.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 362.00 Mn
10 Inventiva 732.26 Mn 182.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 19,299.78
Mar 31, 2020 266,049.31
API Access

Inventiva Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IVA&period=max&api_key=YOUR_API_KEY